Education

Watch “The Science Behind Gene Therapy,” from ASGCT and NORD

ASGCT Staff - October 08, 2019

The webinars in this series are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

The second in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.

This session, held on Sept. 25, explored how gene therapies are developed, the ways in which evidence-based science guides manufacturers of gene therapies, how vectors deliver gene therapies to cells, and what happens inside the body after gene therapy is delivered. Speakers include Sven Kili, M.D., a member of the ASGCT Outreach and Communications Committee and a strategic consultant for regenerative medicine companies, and Tiffany Lucas, Ph.D., an FDA product reviewer in the division of gene therapy in the Center for Biologics Evaluation and Research (CBER).

Mark your calendar for the rest of the sessions in this free webinar series. All the webinars are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

  • The FDA’s Role in Gene Therapy—Wednesday, October 30
  • Understanding the Gene Therapy Process and Aftercare – Wednesday, November 20
  • Life After Gene Therapy – Wednesday, December 18

The first webinar, “Gene Therapy: Yesterday, Today and Tomorrow,” is available for free here.

Share This Page

Related Articles

Education

Learn About Gene Therapy for Huntington’s Disease

ASGCT Staff - October 15, 2019
ASGCT News

ASGCT Education Program Returns, Covers Parkinson's Disease

ASGCT Staff - October 10, 2019

Rhoda Baer acquired from National Cancer Institute

Advocacy

Bridging the Gap Between Scientists And Patients In Gene Therapy Development

David Barrett, J.D. - September 27, 2019

FDA photo

Education

Margaret Hamburg, M.D. to Speak at Policy Summit

ASGCT Staff - September 26, 2019